Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population
Nacs. Wong et al., Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population, TOX LETT, 115(1), 2000, pp. 17-22
The gene encoding the xenobiotic-metabolising microsomal enzyme, epoxide hy
drolase (mEPHX), shows two common mutations, i.e. at exons 3 and 4. It is u
nknown how these genetic polymorphisms relate to risk of developing alcohol
ic liver disease (ALD) and/or hepatocellular carcinoma (HCC) in a Caucasian
population. DNA samples extracted from the blood of 61 ALD patients and 20
3 healthy controls, and from archival liver tissue of 46 cases of HCC, were
subjected to polymerase chain reaction amplification followed by digestion
with EcoR V or Rsa I to demonstrate polymorphisms of exon 3 or 4, respecti
vely. The distributions of the genotypes of exon 3 in the ALD and HCC patie
nts, and exon 4 in the HCC patients did not differ significantly from those
of the control group. However, compared with the control group, the ALD gr
oup contained a significantly greater number of individuals homozygous or h
eterozygous for the exon 4 mutation. This suggested association between pos
session of the exon 4 mutant mEPHX allele and increased risk of developing
ALD may relate to known interactions between mEPHX and alcohol-metabolising
enzyme systems, or to linkage disequilibrium between the mutation and othe
r genetic risk factors for ALD. (C) 2000 Elsevier Science Ireland Ltd. All
rights reserved.